Exact Sciences gains FDA approval for at-home colon cancer test

08/11/2014 | FoxNews.com

The FDA on Monday approved an at-home, DNA-based colorectal screening test from Exact Sciences that can spot genetic mutations linked to cancerous and precancerous growth in the colon. The Cologuard test was able to detect more cancers during clinical trials compared with blood testing. The test isn't meant to replace more thorough evaluation methods, such as colonoscopy, but rather to encourage more people to be screened, doctors say.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID